-
A Phase 2 Double-blind Placebo-Controlled Study to Evaluate LY3537021 for the Treatment of Chemotherapy-Induced Nausea and Vomiting in Adult Participants With Malignant Disease
This is a Phase 2 study testing how safe and effective a medicine called LY3537021 is when added to standard anti-nausea treatment. LY3537021 is a ...
Phase
Interventional
-
A Global Phase 2b Randomized Double-Blinded Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy FORTITUDE-HCM
The purpose of this study is to examine the effects of ninerafaxstat (an investigational drug) in people who are experiencing symptoms from their Non-Obstructive Hypertrophic ...Phase
Interventional
-
An Open-label Multi-center Global Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Subjects with Advanced Non-small Cell Lung Cancer (NSCLC)
HLX43 is a fully human monoclonal antibody drug conjugate targeting PD-L1, which is prepared by conjugating an antibody specifically targeting PD-L1 to a toxin-peptide chain ...Phase
Interventional
-
A Phase 2 Randomized Double-blind Placebo-controlled Parallel Study Evaluating the Safety and Efficacy of LB-P8 in Patients with Primary Sclerosing Cholangitis (PSC)
This main purpose of this placebo-controlled study to assess the safety and efficacy of LB-P8 in adult patients with Primary Sclerosing Cholangitis (PSC). The study ...Phase
Interventional
